These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1352273)

  • 1. A single base mutation in the gene for type III collagen (COL3A1) converts glycine 847 to glutamic acid in a family with Ehlers-Danlos syndrome type IV. An unaffected family member is mosaic for the mutation.
    Richards AJ; Ward PN; Narcisi P; Nicholls AC; Lloyd JC; Pope FM
    Hum Genet; 1992 Jun; 89(4):414-8. PubMed ID: 1352273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The substitution of glycine 661 by arginine in type III collagen produces mutant molecules with different thermal stabilities and causes Ehlers-Danlos syndrome type IV.
    Richards A; Narcisi P; Lloyd J; Ferguson C; Pope FM
    J Med Genet; 1993 Aug; 30(8):690-3. PubMed ID: 8411057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A COL3A1 glycine 1006 to glutamic acid substitution in a patient with Ehlers-Danlos syndrome type IV detected by denaturing gradient gel electrophoresis.
    Johnson PH; Richards AJ; Pope FM; Hopkinson DA
    J Inherit Metab Dis; 1992; 15(3):426-30. PubMed ID: 1357232
    [No Abstract]   [Full Text] [Related]  

  • 4. A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.
    Cole WG; Chiodo AA; Lamande SR; Janeczko R; Ramirez F; Dahl HH; Chan D; Bateman JF
    J Biol Chem; 1990 Oct; 265(28):17070-7. PubMed ID: 2145268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of a glycine to valine substitution at amino acid position 910 of the triple helical region of type III collagen in a patient with Ehlers-Danlos syndrome type IV.
    Richards AJ; Lloyd JC; Ward PN; De Paepe A; Narcisi P; Pope FM
    J Med Genet; 1991 Jul; 28(7):458-63. PubMed ID: 1895316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.
    Chiodo AA; Sillence DO; Cole WG; Bateman JF
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):939-43. PubMed ID: 7487954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of aspartate for glycine 1018 in the type III procollagen (COL3A1) gene causes type IV Ehlers-Danlos syndrome: the mutated allele is present in most blood leukocytes of the asymptomatic and mosaic mother.
    Kontusaari S; Tromp G; Kuivaniemi H; Stolle C; Pope FM; Prockop DJ
    Am J Hum Genet; 1992 Sep; 51(3):497-507. PubMed ID: 1496983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 27-bp deletion from one allele of the type III collagen gene (COL3A1) in a large family with Ehlers-Danlos syndrome type IV.
    Richards AJ; Lloyd JC; Narcisi P; Ward PN; Nicholls AC; De Paepe A; Pope FM
    Hum Genet; 1992 Jan; 88(3):325-30. PubMed ID: 1370809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen.
    Narcisi P; Richards AJ; Ferguson SD; Pope FM
    Hum Mol Genet; 1994 Sep; 3(9):1617-20. PubMed ID: 7833919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-strand conformation polymorphism (SSCP) analysis of the COL3A1 gene detects a mutation that results in the substitution of glycine 1009 to valine and causes severe Ehlers-Danlos syndrome type IV.
    Nuytinck L; De Paepe A; Renard JP; Adriaens F; Leroy J
    Hum Mutat; 1994; 3(3):268-74. PubMed ID: 8019562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A T+6 to C+6 mutation in the donor splice site of COL3A1 IVS7 causes exon skipping and results in Ehlers-Danlos syndrome type IV.
    Lloyd J; Narcisi P; Richards A; Pope FM
    J Med Genet; 1993 May; 30(5):376-80. PubMed ID: 8320698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single base mutation that substitutes glutamic acid for glycine 1021 in the COL3A1 gene and causes Ehlers-Danlos syndrome type IV.
    Narcisi P; Wu Y; Tromp G; Earley JJ; Richards AJ; Pope FM; Kuivaniemi H
    Am J Med Genet; 1993 May; 46(3):278-83. PubMed ID: 8098182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal extracellular matrix in Ehlers-Danlos syndrome type IV due to the substitution of glycine 934 by glutamic acid in the triple helical domain of type III collagen.
    McGrory J; Weksberg R; Thorner P; Cole WG
    Clin Genet; 1996 Dec; 50(6):442-5. PubMed ID: 9147870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single base mutation in the type III procollagen gene that converts the codon for glycine 883 to aspartate in a mild variant of Ehlers-Danlos syndrome IV.
    Tromp G; Kuivaniemi H; Stolle C; Pope FM; Prockop DJ
    J Biol Chem; 1989 Nov; 264(32):19313-7. PubMed ID: 2808425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ehlers-Danlos syndrome type IV is associated with a novel G984R COL3A1 mutation.
    Deng Y; Wei S; Hu S; Chen J; Tan Z; Yang Y
    Mol Med Rep; 2015 Jul; 12(1):1119-24. PubMed ID: 25776230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV.
    Nuytinck L; Narcisi P; Nicholls A; Renard JP; Pope FM; De Paepe A
    J Med Genet; 1992 Jun; 29(6):375-80. PubMed ID: 1619632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring.
    Milewicz DM; Witz AM; Smith AC; Manchester DK; Waldstein G; Byers PH
    Am J Hum Genet; 1993 Jul; 53(1):62-70. PubMed ID: 8317500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ehlers-Danlos syndrome type IV caused by Gly400Glu, Gly595Cys and Gly1003Asp substitutions in collagen III: clinical features, biochemical screening, and molecular confirmation.
    Mackay K; Raghunath M; Superti-Furga A; Steinmann B; Dalgleish R
    Clin Genet; 1996 Jun; 49(6):286-95. PubMed ID: 8884076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability?
    Giunta C; Steinmann B
    Am J Med Genet; 2000 Jan; 90(1):72-9. PubMed ID: 10602121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing and a novel COL3A1 mutation associated with vascular Ehlers-Danlos syndrome with severe intestinal involvement: a case report.
    Cortini F; Marinelli B; Seia M; De Giorgio B; Pesatori AC; Montano N; Bassotti A
    J Med Case Rep; 2016 Oct; 10(1):303. PubMed ID: 27799058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.